Senzime Launches TetraCom Connectivity Platform Enabling Universal Transmission of Anesthesia Data

Rhea-AI Summary

Senzime (OTCQX:SNZZF) launched TetraCom on February 19, 2026, a hospital connectivity platform that transmits real-time neuromuscular data from the TetraGraph monitor into major EHRs like Epic and Oracle Health (Cerner).

TetraCom combines a compact hardware gateway and cloud software using HL7 messaging to enable wireless, monitor-independent data interoperability and automated, guideline-compliant documentation; initial availability is in the US market.

UPPSALA, SE / ACCESS Newswire / February 19, 2026 / Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF) today announced the launch of the TetraCom ^TM hospital connectivity platform. TetraCom is a first of its kind platform, enabling universal transmission of neuromuscular data directly into leading hospital enterprise systems such as Epic and Oracle Health (Cerner).

TetraCom^™ is a unique connectivity platform designed to seamlessly transmit real-time data from the Senzime TetraGraph ^® neuromuscular monitor to virtually any electronic health record (EHR) and clinical information system. The TetraCom platform consists of a compact hardware gateway and a cloud-based software solution with industry-standard HL7 messaging, enabling cost-effective, wireless universal data interoperability across hospital enterprise systems without custom integration.

"We continue to drive innovation in the operating room introducing the first dedicated and AI-ready connectivity platform designed specifically for neuromuscular transmission data. TetraCom enables us to generate additional value from data integration as a complement to the TetraGraph-system. The customer value is clear; cost-effective direct integration, eliminated manual charting and guideline-compliant automated documentation across cases and care teams", said Philip Siberg, CEO of Senzime.

The TetraCom complements Senzime's existing connectivity solutions by offering a direct-to-EHR pathway for hospitals seeking streamlined, monitor-independent integration.

TetraCom is initially only available in the US market. For more information about the TetraCom and Senzimes's connectivity solutions, visit Senzime.com/Connectivity.

For further information, please contact:

Philip Siberg, CEO of Senzime AB
Phone: +46 (0) 707 90 67 34, e-mail: philip.siberg@senzime.com

About Senzime

Senzime is a leading medical device company at the forefront of a changing healthcare market, driven by new clinical guidelines and emerging technologies. Established in 1999, Senzime develops and markets precision-based monitoring systems that improve outcomes, reduce costs, and advance perioperative patient safety. The flagship solution is the TetraGraph^® system, proven best-in-class for accurate monitoring of neuromuscular transmission during surgery and used in thousands of operating rooms across the globe. The system helps to secure precise dosing of paralytic drugs and provides enhanced insights to safeguard every patient's journey, from anesthesia to recovery.

Headquartered in Uppsala, Sweden, Senzime is publicly traded on the Nasdaq Stockholm Main Market (SEZI), with cross-trading on the US OTCQX Market (SNZZF), and backed by long-term investors. More information is available at senzime.com.

Attachments

Senzime launches TetraCom connectivity platform enabling universal transmission of anesthesia data

SOURCE: Senzime

View the original press release on ACCESS Newswire

FAQ

What is Senzime's TetraCom platform and how does it work (SNZZF, Feb 19, 2026)?

TetraCom is a connectivity platform that transmits neuromuscular data directly into EHRs using HL7 messaging. According to the company, it pairs a compact hardware gateway with cloud software to enable wireless, monitor-independent integration and automated documentation into Epic and Oracle Health.

Which hospital systems does TetraCom support and is it available now for SNZZF investors?

TetraCom supports major enterprise systems such as Epic and Oracle Health (Cerner). According to the company, the platform uses industry-standard HL7 messaging and is initially available in the US market as of February 19, 2026.

How does TetraCom affect clinical workflows and charting for hospitals using SNZZF's TetraGraph?

TetraCom aims to eliminate manual charting and automate guideline-compliant documentation across cases and teams. According to the company, direct-to-EHR transmission reduces manual steps and enables real-time neuromuscular data visibility in the patient record.

Does TetraCom require custom integration for hospitals deploying SNZZF connectivity?

No, TetraCom is designed to avoid custom integrations by using HL7 messaging and a cloud gateway. According to the company, this approach delivers cost-effective universal interoperability without bespoke hospital interfacing work.

Where can investors find more information about Senzime's TetraCom and availability (SNZZF)?

Investors can find product and availability details on the company's connectivity page. According to the company, more information is available at Senzime.com/Connectivity and TetraCom is initially offered in the US market.